First Time Loading...

Dynavax Technologies Corp
NASDAQ:DVAX

Watchlist Manager
Dynavax Technologies Corp Logo
Dynavax Technologies Corp
NASDAQ:DVAX
Watchlist
Price: 11.21 USD 0.36% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

DVAX Price Targets Summary
Dynavax Technologies Corp

Wall Street analysts forecast DVAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVAX is 26.27 USD with a low forecast of 20.2 USD and a high forecast of 30.45 USD.

DVAX Lowest Forecast
Wall Street Target
20.2 USD
80% Upside
DVAX Average Forecast
Wall Street Target
26.27 USD
134% Upside
DVAX Highest Forecast
Wall Street Target
30.45 USD
172% Upside
Lowest
Price Target
20.2 USD
80% Upside
Average
Price Target
26.27 USD
134% Upside
Highest
Price Target
30.45 USD
172% Upside
Dynavax Technologies Corp Competitors:
Price Targets
KNSA
Kiniksa Pharmaceuticals Ltd
64% Upside
6160
Beigene Ltd
50% Upside
300685
Amoy Diagnostics Co Ltd
41% Upside
G
GNFT
Genfit SA
201% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
64% Upside
6160
Beigene Ltd
50% Upside
300685
Amoy Diagnostics Co Ltd
41% Upside
G
GNFT
Genfit SA
201% Upside
NIOX
Niox Group PLC
16% Upside
PRLD
Prelude Therapeutics Inc
45% Upside
QNCX
Quince Therapeutics Inc
183% Upside
603087
Gan & Lee Pharmaceuticals
25% Upside

Revenue
Forecast

Revenue Estimate
Dynavax Technologies Corp

For the last 8 years the compound annual growth rate for Dynavax Technologies Corp's revenue is 66%. The projected CAGR for the next 3 years is 22%.

66%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Dynavax Technologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Dynavax Technologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
What are analyst estimates?

See Also

Summary
DVAX intrinsic value, competitors valuation, and company profile.
DCF Valuation
DVAX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DVAX stock valuation using valuation multiples.
Wall Street Estimates
DVAX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DVAX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DVAX's stock price target?
Price Target
26.27 USD

According to Wall Street analysts, the average 1-year price target for DVAX is 26.27 USD with a low forecast of 20.2 USD and a high forecast of 30.45 USD.

What is Dynavax Technologies Corp's Revenue forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Dynavax Technologies Corp's revenue is 66%. The projected CAGR for the next 3 years is 22%.

ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.